GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Fresenius Medical Care AG (NYSE:FMS) » Definitions » Forward Dividend Yield %

Fresenius Medical Care AG (Fresenius Medical Care AG) Forward Dividend Yield %

: 0.00% (As of Today)
View and export this data going back to 1996. Start your Free Trial

As of today (2024-04-17), the Forward Annual Dividend Yield of Fresenius Medical Care AG is 0.00%.

As of today (2024-04-17), the Trailing Annual Dividend Yield of Fresenius Medical Care AG is 0.00%.

FMS's Forward Dividend Yield % is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 2.225
* Ranked among companies with meaningful Forward Dividend Yield % only.

Fresenius Medical Care AG's Dividends per Share for the three months ended in Dec. 2023 was $0.00.

During the past 12 months, Fresenius Medical Care AG's average Dividends Per Share Growth Rate was -17.00% per year. During the past 3 years, the average Dividends Per Share Growth Rate was -2.30% per year. During the past 5 years, the average Dividends Per Share Growth Rate was 2.40% per year. During the past 10 years, the average Dividends Per Share Growth Rate was 6.50% per year.

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Fresenius Medical Care AG was 13.50% per year. The lowest was -2.30% per year. And the median was 8.10% per year.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.


Competitive Comparison

For the Medical Care Facilities subindustry, Fresenius Medical Care AG's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Fresenius Medical Care AG Forward Dividend Yield % Distribution

For the Healthcare Providers & Services industry and Healthcare sector, Fresenius Medical Care AG's Forward Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Fresenius Medical Care AG's Forward Dividend Yield % falls into.



Fresenius Medical Care AG Forward Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.


Fresenius Medical Care AG  (NYSE:FMS) Forward Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.


Fresenius Medical Care AG Forward Dividend Yield % Related Terms

Thank you for viewing the detailed overview of Fresenius Medical Care AG's Forward Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Fresenius Medical Care AG (Fresenius Medical Care AG) Business Description

Address
Else-Kroener-Strasse 1, Bad Homburg, HE, DEU, 61352
Fresenius Medical Care is the largest dialysis company in the world, treating about 345,000 patients from over 4,100 clinics across the globe as of December 2022. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market and benefits from being the world's only fully integrated dialysis business. Services account for roughly 80% of firmwide revenue, including care coordination and ancillary operations, while products account for the other roughly 20%. Products typically enjoy a higher margin, making them a strong contributor to the bottom line.
Executives
Helen Pring Giza Board of Directors